Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease (IMAS)

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
University of Southampton
ClinicalTrials.gov Identifier:
NCT00974805
First received: September 8, 2009
Last updated: December 5, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)